Gapping up
News:
- COWN +14.4% (Toronto-Dominion Bank (TD) is considering possible bid for COWN, according to Bloomberg)
- DYN +11.1% (FDA lifts clinical hold, clears IND application to initiate clinical trial of DYNE-251)
- OCFT +10.8% (successfully lists on the Main Board of the Stock Exchange of Hong Kong)
- REI +6.4% (acquires Stronghold's Permian Basin assets)
- DRIO +5.9% (files for 226,586 share common stock offering by selling shareholder related to warrants)
- TRP +4.5% (agreed with Mexico to build a $5 bln gas pipeline in Veracruz, according to Reuters)
- VET +3.6% (receives TSX approval for normal course issuer bid)
- ASTS +3.5% (sells majority stake in NanoAvionics)
- FULC +3.3% (enrolls first patient in pivotal global Phase 3 clinical trial of Losmapimod)
- QD +2.4% (completes the optional repurchase of 1.00% Convertible Senior Notes due 2026)
- ISEE +1.6% (IVERIC bio and DelSiTech Ltd announce an exclusive global license agreement for new formulations of Zimura; ISEE to make upfront payment of €1.25 mln)
- OXY +1.2% (10% owner Berkshire Hathaway (Warren Buffett) bought 9,887,040 shares worth ~$582.4mln)
Analyst comments:
- AR +2.2% (upgraded to Buy from Hold at Truist)